IRulya Therapeutics QNCX
NASDAQ QNCX
$32.83 -1.85 (-5.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Quince Therapeutics (QNCX) Cash & Current Investments (2018 - 2026)

Updated

IRulya Therapeutics' Cash & Current Investments came in at $116 million for Q2 2026, up 234.2% from $34.71 million a year earlier and up 537.4% from the prior quarter.

Analysis

Quince Therapeutics (QNCX) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, IRulya Therapeutics' Cash & Current Investments was $17.75 million, down 56.5% from FY2024.

  • Cash & Current Investments has declined in each of the last five years, with a five-year compound annual growth rate of -33.2% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $40.78 million in FY2024 (-45.7%), $75.06 million in FY2023 (-16.8%), $90.18 million in FY2022 (-15.6%) and $106.8 million in FY2021 (-20.2%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments since Q2 2021.
  • Year-over-year, Cash & Current Investments increased in 1 of the last eight quarters, with an average decline of 11.6%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 234.2%), and the weakest in Q4 2025 (a decline of 56.5%).
  • Business Quant data shows QNCX's Cash & Current Investments at $18.2 million (Q1 2026), $17.75 million (Q4 2025) and $26.29 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 IRulya Therapeutics 201.34 Mn 229.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116.00 Mn
Mar 31, 2026 18.20 Mn
Dec 31, 2025 17.75 Mn
Sep 30, 2025 26.29 Mn
Jun 30, 2025 34.71 Mn
Mar 31, 2025 31.60 Mn
Dec 31, 2024 40.78 Mn
Sep 30, 2024 47.85 Mn
Jun 30, 2024 59.45 Mn
Mar 31, 2024 67.82 Mn
Dec 31, 2023 75.06 Mn
Sep 30, 2023 83.23 Mn
Jun 30, 2023 87.57 Mn
Mar 31, 2023 90.20 Mn
Dec 31, 2022 90.18 Mn
Sep 30, 2022 94.34 Mn
Jun 30, 2022 94.66 Mn
Mar 31, 2022 91.52 Mn
Dec 31, 2021 106.80 Mn
Sep 30, 2021 114.41 Mn
API Access

Quince Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=QNCX&period=max&api_key=YOUR_API_KEY